MedComm (2020) April 2023 PMID 36814688

Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study.

Heng-Chung Kung, Jun Yu

Download social card

Mentions

Peak: 5 in Feb 2023

across 2 sources since Feb 2023

Extended reach

11,184

potential audience

Total likes

Video views

Mentions per month

Feb 2023 – Jul 2023

Where it's discussed

X / Twitter5 posts
YouTube1 videos

AI synopsis

What people are saying

The discussions highlight the review's role in linking molecular mechanisms with clinical development, as seen in phrases like 'bridges the molecular understanding' and 'shifting directions in treatment paradigm,' emphasizing both interest and perceived importance in advancing PDAC research.

AgreementModerate agreement

Most discussions acknowledge the importance of the review in connecting molecular insights with clinical applications, indicating general agreement.

InterestModerate interest

Participants show moderate interest by engaging with the review's relevance to developing new therapies and treatment strategies.

EngagementModerate engagement

Comments reflect a thoughtful engagement, emphasizing the significance of the review in advancing understanding of PDAC.

ImpactModerate impact

The conversations suggest the review could influence future research directions and therapeutic approaches, indicating a moderate impact.

Abstract in brief

PDAC is a highly aggressive and lethal cancer with poor survival rates due to challenges like late detection, complex molecular pathways, dense stroma, and an immunosuppressive environment.
The review covers key signaling pathways, molecular mechanisms, and the tumor microenvironment involved in PDAC, along with current and future treatment strategies such as neoadjuvant therapy and targeted therapy.
It highlights ongoing research, clinical trials, and the importance of integrating molecular insights into developing new therapies and improving treatment approaches for PDAC.]

Read the full abstract

All mentions

Targeted Therapy and Mechanisms in Pancreatic Ductal Adenocarcinoma

This video discusses the aggressive nature of pancreatic ductal adenocarcinoma, exploring molecular pathways, tumor microenvironment, and current treatment strategies, emphasizing ongoing research and clinical trials…

Medicine RTCL TV · Jul 24, 2023 44 views

Mercedes Pia

@MercedesPiedad · X

RT @PancreaticCell:

Feb 22, 2023 · 2 shares · 109 followers View post →

Precision Clinical Medicine

@PrecisionClinMe · X

RT @MedComm_MC: [MedComm] REVIEW This review bridges the molecular understanding of #Pancreatic_ductal_adenocarcinoma with its clinical sig…

Feb 22, 2023 · 1 share · 7,920 followers View post →

MedComm

@MedComm_MC · X

Feb 22, 2023 · 2 likes · 1 share · 245 followers View post →

Aysun Değirmenci, PhD

@degirmenciaysn · X

RT @PancreaticCell:

Feb 21, 2023 · 2 shares · 118 followers View post →

Pancreatic Cell News

@PancreaticCell · X

Feb 21, 2023 · 6 likes · 2 shares · 2,733 followers View post →